Keywords: Lupus, SLE, Drug development, GlaxoSmithKline, Benlysta, Anthera, Blisibimod, GlobalData

Barriers to overcome in lupus drug development

Article | 22 July 2012

Print This

It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in